NEW YORK (GenomeWeb News) – Erasmus University Medical Center in the Netherlands is using Ingenuity Systems’ software in its next-generation sequencing-based disease and compound studies under a collaboration announced by Ingenuity today.
Erasmus is using Ingenuity’s IPA software and its Knowledge Base and is working with the company to help map and study genes and variants linked to biological processes, functions, diseases, pathways, compounds, and relationships in order to obtain "a more complete biological picture from their NGS data," the company said.
"Like many researchers, we faced the challenge of sifting through thousands of variants in order to rapidly identify the few that were the best candidates for follow-up studies and those most likely to be causal for our disease phenotype," EUMC Professor Peter van der Spek said in a statement.
"IPA helped us overcome this challenge and discover a novel causal variant in a disease area of interest. It provides the critical biological context necessary to realize the full potential of NGS datasets,” van der Spek added.
Financial terms of the agreement were not released.